|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| A61K 45/06 | |||
| A61P 11/00 |
| (11) | Number of the document | 3528812 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17787029.2 |
| Date of filing the European patent application | 2017-10-09 | |
| (97) | Date of publication of the European application | 2019-08-28 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2017/056226 |
| Date | 2017-10-09 |
| (87) | Number | WO 2018/073687 |
| Date | 2018-04-26 |
| (30) | Number | Date | Country code |
| 201662410566 P | 2016-10-20 | US | |
| 201762548629 P | 2017-08-22 | US |
| (72) |
EVANS, Steven Martin, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | PALBOCICLIB FOR TREATING PAH |
| PALBOCICLIB FOR TREATING PAH |